Josef S. Smolen

发表

Extended Report

W. Dixon, D. M. van der Heijde, S. Suissa, 2022 .

Overexpression of transcription factor Ets-1 in rheumatoid arthritis synovial membrane: regulation of expression and activation by interleukin-1 and tumor necrosis factor alpha.

I. Radda, K. Redlich, G. Stummvoll, 2001, Arthritis and rheumatism.

Relation of Nailfold Capillaries and Autoantibodies to Mortality in Patients With Raynaud’s Phenomenon

J. Gamper, G. Giurgea, M. Gschwandtner, 2016 .

The role of T-lymphocytes and cytokines in rheumatoid arthritis.

A. Falus, J. Smolen, G. Eberl, 1996, Scandinavian journal of rheumatology.

Differential antibody recognition of the 349–364aa B-cell epitope of human La/SSB protein and its phosphorylated analogue

A. Radbruch, K. Redlich, R. Manz, 2004, The Journal of experimental medicine.

Patients with Rheumatoid Arthritis Ribonucleoprotein A 2 ( RA 33 ) and Filaggrin the Autoantigens Heterogeneous Nuclear Characterization of Autoreactive T Cells to

K. Skriner, J. Smolen, C. Scheinecker, 2002 .

Protein microarray characterization of autoantibody responses in rheumatoid arthritis and systemic lupus erythematosus

Lawrence Steinman, Josef S. Smolen, Gabriel S. Panayi, 2002, Arthritis Research.

Characterization of Autoreactive T Cells to the Autoantigens Heterogeneous Nuclear Ribonucleoprotein A2 (RA33) and Filaggrin in Patients with Rheumatoid Arthritis1

K. Skriner, J. Smolen, C. Scheinecker, 2002, The Journal of Immunology.

TNFα mediates susceptibility to heat-induced apoptosis by protein phosphatase-mediated inhibition of the HSF1/hsp70 stress response

G. Schett, J. Smolen, G. Steiner, 2003, Cell Death and Differentiation.

Are autoantibodies active players or epiphenomena?

J. Smolen, G. Steiner, Josef S. Smolen, 1998, Current opinion in rheumatology.

Zoledronic acid protects from local and systemic bone loss in tumor necrosis factor-mediated arthritis

K. Redlich, G. Kollias, S. Hayer, 2004, Arthritis Research & Therapy.